Oxidative stress in cancer cell metabolism

S Arfin, NK Jha, SK Jha, KK Kesari, J Ruokolainen… - Antioxidants, 2021 - mdpi.com
Reactive oxygen species (ROS) are important in regulating normal cellular processes
whereas deregulated ROS leads to the development of a diseased state in humans …

Aldo-keto reductases and cancer drug resistance

TM Penning, S Jonnalagadda, PC Trippier… - Pharmacological …, 2021 - Elsevier
Human aldo-keto reductases (AKRs) catalyze the NADPH-dependent reduction of carbonyl
groups to alcohols for conjugation reactions to proceed. They are implicated in resistance to …

Oxidative stress and lipid peroxidation products in cancer progression and therapy

G Barrera - International Scholarly Research Notices, 2012 - Wiley Online Library
The generation of reactive oxygen species (ROS) and an altered redox status are common
biochemical aspects in cancer cells. ROS can react with the polyunsaturated fatty acids of …

The aldo-keto reductases (AKRs): Overview

TM Penning - Chemico-biological interactions, 2015 - Elsevier
The aldo-keto reductase (AKR) protein superfamily contains> 190 members that fall into 16
families and are found in all phyla. These enzymes reduce carbonyl substrates such as …

The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention

JM Peters, YM Shah, FJ Gonzalez - Nature Reviews Cancer, 2012 - nature.com
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription
factors that are involved in regulating glucose and lipid homeostasis, inflammation …

[HTML][HTML] Molecular mechanisms of oxidative stress in stroke and cancer

V Chavda, B Chaurasia, K Garg, H Deora, GE Umana… - Brain Disorders, 2022 - Elsevier
Oxidative stress is a silent participant in all chronic progressive pathology and degenerative
disorders. Neurodegeneration and cognitive impairment are caused by increased …

Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics

EG Armitage, AD Southam - Metabolomics, 2016 - Springer
Introduction Cellular metabolism is altered during cancer initiation and progression, which
allows cancer cells to increase anabolic synthesis, avoid apoptosis and adapt to low nutrient …

Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights

MC Byrns, Y Jin, TM Penning - The Journal of steroid biochemistry and …, 2011 - Elsevier
There is considerable interest in the development of an inhibitor of aldo–keto reductase
(AKR) 1C3 (type 5 17β-hydroxysteroid dehydrogenase and prostaglandin F synthase) as a …

Crosstalk between ROS and autophagy in tumorigenesis: understanding the multifaceted paradox

A Hasan, SF Rizvi, S Parveen, N Pathak, A Nazir… - Frontiers in …, 2022 - frontiersin.org
Cancer formation is a highly regulated and complex process, largely dependent on its
microenvironment. This complexity highlights the need for developing novel target-based …

AKR1C3 (type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase): Roles in malignancy and endocrine disorders

TM Penning - Molecular and cellular endocrinology, 2019 - Elsevier
Abstract Aldo-Keto-Reductase 1C3 (type 5 17β-hydroxysteroid dehydrogenase
(HSD)/prostaglandin (PG) F 2α synthase) is the only 17β-HSD that is not a short-chain …